Table 5.
Outcomes associated with various treatment options for patients with locally recurrent early stage non-small cell lung cancer
| Treatment | Locoregional Recurrence | Positive Margin Rate | |
|---|---|---|---|
| Surgery | Lobectomy | 4.9–7% | 1.4% |
| Segmentectomy | 9.1–16% | 2.1% | |
| Wedge resection | 11–27.8% | 4.0% | |
| Stereotactic body radiotherapya | 8–15% | n/a |
Only includes early stage non-small cell lung cancers